Evidence map›Paper›PMID 26011383›Full record

ArticleJournal of personalized medicine2015

Establishing and sustaining a prospective screening program for breast cancer-related lymphedema at the massachusetts general hospital: lessons learned.

Cheryl Brunelle, Melissa Skolny, Chantal Ferguson, Meyha Swaroop, Jean O'Toole, Alphonse G Taghian

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of personalized medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
2.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Breast Cancer-Related Lymphedema: Risk Factors, Screening, Management, and the Impact of Locoregional Treatment.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2020
    Review
  14. Article
  15. The legacy of lymphedema: Impact on nursing practice and vascular access.Canadian oncology nursing journal = Revue canadienne de nursing oncologique · 2019
    Article
  16. Timing of Lymphedema After Treatment for Breast Cancer: When Are Patients Most At Risk?International journal of radiation oncology, biology, physics · 2019
    Article
  17. Article
  18. Observational
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Cheryl BrunelleDepartment of Physical and Occupational Therapy, Massachusetts General Hospital, Boston, MA 02114, USA. cbrunelle@partners.org.
Melissa SkolnyDepartment of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. mskolny@partners.org.
Chantal FergusonDepartment of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. cferguson4@partners.org.
Meyha SwaroopDepartment of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. mskolny@partners.org.
Jean O'TooleDepartment of Physical and Occupational Therapy, Massachusetts General Hospital, Boston, MA 02114, USA. jotoole244@comcast.net.
Alphonse G TaghianDepartment of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. ataghian@partners.org.
Massachusetts General Hospital · USHarvard University · US

Funding

Early Detection and Treatment of Lymphedema in Women with Breast CancerR01CA139118 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI TAGHIAN, ALPHONSE G · 2009 to 2013
$1.4M
NCI NIH HHS R01 CA139118
6 · The paper itself

Abstract

There has been an increasing call to prospectively screen patients with breast cancer for the development of breast cancer-related lymphedema (BCRL) following their breast cancer treatment. While the components of a prospective screening program have been published, some centers struggle with how to initiate, establish, and sustain a screening program of their own. The intent of this manuscript is to share our experience and struggles in establishing a prospective surveillance program within the infrastructure of our institution. It is our hope that by sharing our history other centers can learn from our mistakes and successes to better design their own prospective screening program to best serve their patient population.

Indexed as

breast cancerbreast cancer-related lymphedemalymphedemaperometerscreening

Identifiers

PMID26011383
PMCPMC4493493
OpenAlexW2162267948

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.